cpi-818
corvus pharma,merck,prometheus bio
['cpi-818', 'prometheus', 'solid tumor', 'merck']
$rxdx prometheus buyout talks with merck. corvus pharma $crvs cpi-818 has different mode of action for th1 skewing and th2/th17 blockade for similar potential tp $rxdx in autoimmune disease. - aacr poster april 17, 2023 solid tumors
- expect fda meeting 2h 2023 phase iii trial 
Organic and Biochemistry, Whisky Enthusiast.  Find undervalued biotech and resource related companies and take large positions to hold.